As CRISPR-Cas9 Technology Sets to Take Off, Uncertainty Swirls Around IP Landscape | GenomeWeb

NEW YORK (GenomeWeb) – As the CRISPR-Cas9 gene editing technology sets to take off, the patent landscape surrounding the method has quickly become muddled with stakeholders seeking a claim to what some are calling a foundational technology.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Startup companies are taking on personalized medicine, CNET reports.

Bruce Booth writes at Life Sci VC that biotech clusters like Boston and San Francisco are getting even more consolidated.

The Verge speaks with Mark and Scott Kelly, who are the subjects of NASA's Twin Study.

In Genome Biology this week: genes linked to Hirschsprung disease, structural variant patterns in autism, and more.